Is Thymosin Alpha-1 Legal in Georgia? How to Access It Legally
HealthRX.com
No federal pharmacy pathway currently covers thymosin alpha-1
Key numbers
- 4 yes and 17 noFDA advisory committee vote on adding thymosin alpha-1 to the pharmacy bulks list, both formsSource: fda.gov, as cited Nov 7, 2026
- RR 0.53Relative risk of all-cause mortality in chronic hepatitis B trials, rated very low certaintySource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 1.6 mgDose of the finished Zadaxin injection sold outside the USSource: fda.gov, as cited Nov 7, 2026
At a glance
- FDA approval / None; four orphan designations are not approvals [1]
- Approved abroad / Italy, India and Hong Kong [1]
- FDA committee vote / 4 yes, 17 no on both forms [5]
- Pharmacy list / In none of the three categories [2]
- Outsourcing list / Category 3, nominated without adequate support [3]
What is thymosin alpha-1?
A 28-amino-acid peptide first isolated from thymosin fraction 5, a thymus extract. Thymalfasin is the synthetic version; Zadaxin is the brand of the finished 1.6 mg injection sold outside the US and is not interchangeable with bulk powder [1]. It augments T-cell function, peaks about 0.7 to 2 hours after subcutaneous injection, has a half-life of about 1.8 to 2.6 hours, and did not accumulate over five daily doses [6][1].
Is it FDA-approved?
No. Drugs@FDA returns no application, and the four US orphan drug designations are not approvals [1]. FDA's December 2024 review lists Italy, where Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people; India, for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication; and Hong Kong [1].
Can a US pharmacy compound it?
Thymosin alpha-1 appears in none of the three categories on FDA's list for state-licensed pharmacies (updated May 14, 2026) [2]. It sits in the 'nominated but withdrawn' table after nominators withdrew it from category 2 for significant safety risks. FDA's concerns remain posted: significant risk of immunogenicity for certain routes, peptide impurity and characterization problems, and safety information inadequate to understand the extent of any safety issues [7]. FDA's category 1 policy does not apply [2].
FDA proposed that it not be added to the pharmacy bulks list. On December 4, 2024 the Pharmacy Compounding Advisory Committee voted 4 yes and 17 no on both the free base and the acetate; members who voted no cited no compelling evidence of clinical effectiveness and safety [5]. For outsourcing facilities it is category 3, 'nominated without adequate support' [3]. It is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy, and no FDA or HHS action allowing it to be compounded was found [4].
Questions worth asking
Can you import Zadaxin?
FDA says it is illegal in most circumstances to import drugs for personal use, including a drug approved abroad but unapproved in the US [8]. FDA personnel may consider a more permissive decision in limited situations, such as a serious condition with no effective domestic treatment, a written statement that the product is for personal use, and a supply of generally not more than three months, together with either the name and address of a US-licensed doctor responsible for treatment or evidence of a treatment begun abroad [8]. That is case-by-case, not a standing permission.
What is known about safety and evidence?
An FDA adverse-event database search on April 22, 2024 found zero reports [1]. Authors tied to the manufacturer report more than 4,400 trial enrollees and more than 17 million doses after marketing, with adverse experiences 'infrequent and mild'; treat that as company-linked data [1]. A 2026 Cochrane review of 10 randomized trials in 1,349 adults with chronic hepatitis B found possibly lower all-cause mortality (RR 0.53, 95% CI 0.29 to 0.96) but rated the certainty very low, and the reviewers said they were 'not sure' it helps [9]. For the Italian Zadaxin 1.6 mg product, the label says it is not for children, is contraindicated in pregnancy and breastfeeding, and should be used with caution in people with allergies or autoimmune disease and with other immune-modulating medicines [1].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is thymosin alpha-1 FDA-approved?
Can a US pharmacy compound thymosin alpha-1 on prescription?
Can I import Zadaxin from Italy for personal use?
References
Show all 9 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- U.S. Food and Drug Administration.
- Ancell CD, Phipps J, Young L. Thymosin alpha-1. Am J Health Syst Pharm. 2001;58(10):879-85; quiz 886-8.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Personal Importation | FDA.
- Naing C, Ni H, Aung HH, Aye SN, Nikolova D, Poovorawan Y, et al. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database Syst Rev. 2026;9(9):CD014610.